Grading system improves surgical outcomes of multicurrent pterygia

Article

Residual conjunctiva measurements and caruncle morphological characteristics help grade recurrent pterygium severity, assist in surgical techniques and predict the surgical outcomes.

Residual conjunctiva measurements and caruncle morphological characteristics help grade recurrent pterygium severity, assist in surgical techniques and predict the surgical outcomes, claims a study in the journal Archives of Ophthalmology.

The investigation, led by Dr Jingbo Liu, Ocular Surface Centre, Miami, Florida, USA, consisted of 32 eyes of 30 pterygia patients. All participants were managed at the Ocular Surface Centre between January 1 2002 and December 21 2010.

Eyes were successively operated on by recession, sealing of the gap, covering of exposed medial rectus muscle by amniotic membrane, conjunctival autograft or oral mucosal graft (OMG) and the covering of the bare sclera with amniotic membrane. The main outcome measures were recurrence, diplopia and caruncle morphological characteristics.

The findings demonstrated a strong correlation between caruncle grading and residual conjunctiva, severity of diplopia and overall success rate. In 23 eyes with residual conjunctiva of 27.8 mm the amniotic membrane transplantation was enough.

The residual conjunctiva was significantly longer in the six patients who underwent failed amniotic membrane transplantation. A further eight patients experienced successful transplantation, but required additional conjunctival autografts or oral mucosal grafts.

Total success was seen in 30 of 32 eyes and 17 of 21 eyes didn't experience recurrence, diplopia and normal caruncle. Only one eye presented with a depressed caruncle and residual diplopia.

The study revealed that sealing the gap is essential for creating a strong barrier to prevent recurrence, to restore caruncle morphological characteristics and regain complete motility in multirecurrent pterygia.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
© 2025 MJH Life Sciences

All rights reserved.